UK calls China a major challenge but an essential economic partner
Foreign Secretary David Lammy said 'China's power is an inescapable fact' and freezing relations with the world's second biggest economy is 'not an option.' He spoke to lawmakers as he outlined findings from the government's 'China audit.'
'China is our third biggest trading partner, our universities' second largest source of international students. China will continue to play a vital role in supporting the U.K.'s secure growth,' Lammy said.
The Labour Party government pledged to conduct an in-depth examination of U.K.-China relations after it was elected almost a year ago, in an effort to balance the country's economic interests and its security. Many details of the review will remain classified for security reasons, Lammy said.
Its conclusions were summarized in a document outlining the U.K. government's broader national security strategy. It said that 'instances of China's espionage, interference in our democracy and the undermining of our economic security have increased in recent years.'
Yet the government resisted pressure from China hawks in Parliament to label China a threat on a par with Russia. The security review called it a 'geostrategic challenge' but also an essential player in tackling major issues such as climate change, global health and economic stability.
'We will seek a trade and investment relationship that supports secure and resilient growth, and boosts the U.K. economy,' the government said. 'Yet there are several major areas, such as human rights and cybersecurity, where there are stark differences and where continued tension is likely.'
Opposition Conservative Party foreign affairs spokeswoman Priti Patel said the government was showing 'signs of naivety' about China. Another Conservative lawmaker, Harriet Cross, branded Beijing 'at best unreliable and at worst hostile.'
U.K.-China relations have chilled since the short-lived 'golden era' announced by then-Prime Minister David Cameron in 2015, after a series of spying and cyberespionage allegations, Beijing's crackdown on civil liberties in Hong Kong, a former British colony, and China's support for Russia in the Ukraine war.
There was no immediate comment from China on the review.
China was one of many challenges identified in a review that the government said marked 'a hardening and a sharpening of our approach to national security' in an increasingly dangerous world.
Prime Minister Keir Starmer's government has pledged, along with other NATO members, to increase spending on security to 5% of gross domestic product by 2035. The total includes 3.5% on defense and 1.5% on broader security and resilience.
The U.K. currently spends 2.3% of national income on defense and says that will rise to 2.6% by 2027.
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
9 minutes ago
- Yahoo
Nato defence chiefs hold virtual meeting on Ukraine security guarantees
Nato defence chiefs are due to hold a virtual meeting, a senior alliance official said, as countries pushing for an end to Russia's war on Ukraine devise possible future security guarantees for Kyiv that could help forge a peace agreement. Italian admiral Giuseppe Cavo Dragone, chair of Nato's Military Committee, said that 32 defence chiefs from across the alliance would hold a video conference as a US-led diplomatic push seeks to end the fighting. US general Alexus Grynkewich, Nato's supreme allied commander in Europe, will take part in the talks, Mr Dragone said on social platform X. US president Donald Trump met last Friday with Russian leader Vladimir Putin in Alaska, and on Monday hosted Ukrainian president Volodymyr Zelensky and prominent European leaders at the White House. Neither meeting delivered concrete progress. Mr Trump is trying to steer Mr Putin and Mr Zelensky towards a settlement more than three years after Russia invaded its neighbour, but there are major obstacles. They include Ukraine's demands for Western-backed military assurances to ensure Russia will not mount another invasion in coming years. 'We need strong security guarantees to ensure a truly secure and lasting peace,' Mr Zelensky said in a Telegram post on Wednesday after Russian missile and drone strikes hit six regions of Ukraine overnight. Kyiv's European allies are looking to set up a force that could backstop any peace agreement, and a coalition of 30 countries, including European nations, Japan and Australia, have signed up to support the initiative. Military chiefs are figuring out how that security force might work. The role that the US might play in is unclear. Mr Trump has ruled out sending US troops to help defend Ukraine against Russia. Russia has repeatedly said that it would not accept Nato troops in Ukraine. Attacks on civilian areas in Sumy and Odesa overnight into Wednesday injured 15 people, including a family with three small children, Ukrainian authorities said. Mr Zelensky said the strikes 'only confirm the need for pressure on Moscow, the need to introduce new sanctions and tariffs until diplomacy works to its full potential'.
Yahoo
9 minutes ago
- Yahoo
āshibio licences vantictumab for rare bone disorder
Biotechnology company āshibio has entered an exclusive licencing agreement with Mereo BioPharma for the monoclonal antibody, vantictumab, to treat a rare bone disorder. The agreement aims to facilitate antibody development for the autosomal dominant osteopetrosis type 2 (ADO2) bone condition that currently lacks approved therapies. āshibio will oversee clinical development of vantictumab globally for both adult and paediatric patients. Mereo has granted exclusive rights to āshibio for the development and commercialisation in the US and other regions outside of Europe, where Mereo retains commercial rights. ADO2, also referred to as Albers-Schönberg disease, is a genetic disorder characterised by reduced osteoclast function, leading to dense and brittle bones. It is linked to mutations in the chloride channel 7 (CLCN7) gene, with an incidence rate of one in 20,000 births. Āshibio CEO Pankaj Bhargava stated: 'People living with autosomal dominant osteopetrosis type 2 face a lifetime of bone-related complications resulting in significant morbidity, multiple surgical procedures, chronic pain and impaired quality of life – yet patients have no approved therapy to address the disease. 'Bringing vantictumab into our pipeline reflects our commitment to advancing therapies for rare skeletal conditions and improving the lives of those affected by serious bone disorders.' Vantictumab functions by selectively binding to specific frizzled (Fzd) receptors and inhibiting Wnt (wingless-related integration) signalling pathways. Initially developed for cancer treatment, it has undergone clinical trials in oncology showing a favourable safety and pharmacokinetic profile. Previous studies have generated biomarker data that support the efficacy of vantictumab on osteoclast function, which aids in reducing risks associated with the clinical programme and allows āshibio to expedite the advancement of vantictumab into clinical trials for ADO2. "āshibio licences vantictumab for rare bone disorder" was originally created and published by Pharmaceutical Technology, a GlobalData owned brand. The information on this site has been included in good faith for general informational purposes only. It is not intended to amount to advice on which you should rely, and we give no representation, warranty or guarantee, whether express or implied as to its accuracy or completeness. You must obtain professional or specialist advice before taking, or refraining from, any action on the basis of the content on our site.

Yahoo
9 minutes ago
- Yahoo
Baidu misses revenue estimates on online marketing weakness, AI cloud offsets
-- Baidu (HK:9888) (NASDAQ:BIDU) posted mixed results for the second quarter of fiscal 2025, beating profit expectations while revenue missed analysts' estimates. The company's shares rose around 1% in premarket trading Wednesday. The Chinese tech giant posted earnings per share (EPS) of RMB13.58, topping consensus estimates of RMB13.33. Revenue for the three-month period fell 4% year-over-year to RMB32.71 billion, slightly below the consensus of RMB32.92 billion. Baidu (NASDAQ:BIDU) Core contributed RMB26.3 billion ($3.66 billion), down 2% from a year earlier. Online marketing revenue fell 15% to RMB16.2 billion ($2.27 billion), while non-online marketing revenue rose 34% to RMB10.0 billion ($1.40 billion), supported by growth in the AI Cloud business. Revenue at iQIYI came in at RMB6.6 billion ($926 million), marking an 11% year-on-year decline. "In the second quarter, our AI Cloud business continued to deliver robust and healthy revenue growth, supported by our strengthening full-stack AI capabilities and comprehensive end-to-end AI products and solutions," said Robin Li, co-founder and CEO of Baidu. "We remain focused on AI initiatives that offer the greatest long-term value creation potential, where our technology and innovation can make the most meaningful and lasting impact," he added. Baidu's adjusted EBITDA in Q2 totaled RMB6.5 billion ($906 million), with a margin of 20%. Related articles Baidu misses revenue estimates on online marketing weakness, AI cloud offsets Victoria's Secret Exposed: The Warning Sign Behind the Stock's 52% Collapse Risks Rising? Smart Money Dodged 46%+ Drawdowns on These High-Flying Names Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data